These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10658607

  • 1. Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.
    De Esch IJ, Gaffar A, Menge WM, Timmerman H.
    Bioorg Med Chem; 1999 Dec; 7(12):3003-9. PubMed ID: 10658607
    [Abstract] [Full Text] [Related]

  • 2. Homologs of histamine as histamine H3 receptor antagonists: a new potent and selective H3 antagonist, 4(5)-(5-aminopentyl)-1H-imidazole.
    Vollinga RC, Menge WM, Leurs R, Timmerman H.
    J Med Chem; 1995 Jan 20; 38(2):266-71. PubMed ID: 7830269
    [Abstract] [Full Text] [Related]

  • 3. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
    Stark H, Hüls A, Ligneau X, Purand K, Pertz H, Arrang JM, Schwartz JC, Schunack W.
    Arch Pharm (Weinheim); 1998 Jun 20; 331(6):211-8. PubMed ID: 9713254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.
    Aslanian R, Brown JE, Shih NY, wa Mutahi M, Green MJ, She S, Del Prado M, West R, Hey J.
    Bioorg Med Chem Lett; 1998 Aug 18; 8(16):2263-8. PubMed ID: 9873525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists.
    Masłowska-Lipowicz I, Walczyński K.
    Chem Biol Drug Des; 2014 Jan 18; 83(1):106-18. PubMed ID: 23957330
    [Abstract] [Full Text] [Related]

  • 9. omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
    Tozer MJ, Buck IM, Cooke T, Kalindjian SB, Pether MJ, Steel KI.
    Bioorg Med Chem; 2002 Feb 18; 10(2):425-32. PubMed ID: 11741790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
    Ali SM, Tedford CE, Gregory R, Handley MK, Yates SL, Hirth WW, Phillips JG.
    J Med Chem; 1999 Mar 11; 42(5):903-9. PubMed ID: 10072687
    [Abstract] [Full Text] [Related]

  • 16. Non-Imidazole Histamine H₃ Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines.
    Guryn R, Staszewski M, Stasiak A, McNaught Flores D, Fogel WA, Leurs R, Walczyński K.
    Molecules; 2018 Feb 03; 23(2):. PubMed ID: 29401659
    [Abstract] [Full Text] [Related]

  • 17. Novel H3 receptor antagonists. Sulfonamide homologs of histamine.
    Wolin R, Connolly M, Afonso A, Hey JA, She H, Rivelli MA, Willams SM, West RE.
    Bioorg Med Chem Lett; 1998 Aug 18; 8(16):2157-62. PubMed ID: 9873505
    [Abstract] [Full Text] [Related]

  • 18. A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.
    Ganellin CR, Fkyerat A, Bang-Andersen B, Athmani S, Tertiuk W, Garbarg M, Ligneau X, Schwartz JC.
    J Med Chem; 1996 Sep 13; 39(19):3806-13. PubMed ID: 8809168
    [Abstract] [Full Text] [Related]

  • 19. New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
    Sasse A, Sadek B, Ligneau X, Elz S, Pertz HH, Luger P, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2000 Aug 24; 43(17):3335-43. PubMed ID: 10966752
    [Abstract] [Full Text] [Related]

  • 20. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1998 Oct 08; 41(21):4171-6. PubMed ID: 9767653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.